An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed ...
Key opportunities in Saudi Arabia's synthetic biology market include leveraging government investments and biotechnology advancements driven by Vision 2030. The focus is on reducing oil dependence by ...
An interdisciplinary research team from two working groups at the Centre for Synthetic Biology at TU Darmstadt has developed the first RNA-based genetic switch that precisely replicates the logical ...
Synthetic biology is rapidly emerging as a transformative field with wide-reaching applications, including precision medicine, bio-breeding, and gene editing. At the core of these advancements are ...
Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...
A new review outlines design principles and applications of synthetic membraneless organelles built through liquid-liquid phase separation for use in biotechnology.
Researchers engineered the first RNA-based NAND gate in living cells using deep learning and Bayesian optimization, testing ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump admin backs off claims synthetic vitamin could help autism Despite stating ...
Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at ...
KOMO Biosciences, a developer of non-viral targeted insertion technologies, today announced that it has granted Syngenta, a world leader in agricultural innovation, a Research Evaluation License to ...
By simulating the life cycle of a minimal bacterial cell—from DNA replication to protein translation to metabolism and cell ...
News Medical on MSN
4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer (Copy)
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the promotion of Christine Wolosin to Chief Commercial Officer. Christine, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results